Last reviewed · How we verify
Yunnan Baiyao
Yunnan Baiyao is a traditional Chinese medicine formulation that promotes hemostasis and reduces bleeding through multiple herbal components.
Yunnan Baiyao is a traditional Chinese medicine formulation that promotes hemostasis and reduces bleeding through multiple herbal components. Used for Hemostasis and bleeding control, Traumatic bleeding, Gastrointestinal bleeding.
At a glance
| Generic name | Yunnan Baiyao |
|---|---|
| Sponsor | Peking University Third Hospital |
| Drug class | Traditional Chinese medicine / Herbal preparation |
| Modality | Small molecule |
| Therapeutic area | Hematology / Hemostasis |
| Phase | FDA-approved |
Mechanism of action
The formulation contains a proprietary blend of herbs traditionally used to stop bleeding and promote blood circulation. The exact molecular mechanisms are not fully characterized in Western pharmacological terms, but the preparation is believed to work through multiple pathways including platelet aggregation enhancement, coagulation cascade modulation, and anti-inflammatory effects. It has been used clinically for hemostasis in various bleeding conditions.
Approved indications
- Hemostasis and bleeding control
- Traumatic bleeding
- Gastrointestinal bleeding
Common side effects
- Gastrointestinal upset
- Allergic reactions
Key clinical trials
- Multi-center Clinical Observation and Mechanism Study of Yunnan Baiyao in Different Stages of Diabetic Foot Ulcer (PHASE4)
- Clinical Observation and Mechanism Study of Yunnan Baiyao in Different Stages of Diabetic Foot (PHASE4)
- Effectiveness of Yunnan Baiyao in Improving Fracture Pain (NA)
- Efficacy and Safety Study of Yunnan Baiyao on Minor Recurrent Aphthous Stomatitis (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Yunnan Baiyao CI brief — competitive landscape report
- Yunnan Baiyao updates RSS · CI watch RSS
- Peking University Third Hospital portfolio CI